Natural killer (NK) cells can recognize virus-infected and stressed cells
1 using activating and inhibitory receptors, many of which interact with HLA class I. Although early studies also suggested a functional impact of HLA class II on NK cell activity 2, 3 , the NK cell receptors that specifically recognize HLA class II molecules have never been identified. We investigated whether two major families of NK cell receptors, killer-cell immunoglobulin-like receptors (KIRs) and natural cytotoxicity receptors (NCRs), contained receptors that bound to HLA class II, and identified a direct interaction between the NK cell receptor NKp44 and a subset of HLA-DP molecules, including HLA-DP401, one of the most frequent class II allotypes in white populations 4 
. Using NKp44ζ
+ reporter cells and primary human NKp44
+ NK cells, we demonstrated that interactions between NKp44 and HLA-DP401 trigger functional NK cell responses. This interaction between a subset of HLA-DP molecules and NKp44 implicates HLA class II as a component of the innate immune response, much like HLA class I. It also provides a potential mechanism for the described associations between HLA-DP subtypes and several disease outcomes, including hepatitis B virus infection [5] [6] [7] , graft-versus-host disease 8 and inflammatory bowel disease 9, 10 . With the description of the class Ib family protein HLA-F as a ligand for KIR3DS1 (ref. 11 ), activating and inhibitory NK cell receptors for all HLA class I molecules have been identified. However, HLA class II molecules, which have been associated with the outcome of many inflammatory diseases, have never been shown to serve as ligands for NK cell receptors; thus, their role in the innate immune response has not been investigated. To assess binding of NK cell receptors to HLA class II molecules, we used recombinant human Fc constructs, consisting of the extracellular domain of NK cell receptors fused to the human IgG1 Fc domain, in an HLA class II bead-based screening assay. Binding of ten NK cell receptor (NKp30, NKp44, NKp46, KIR2DL3, KIR2DL1, KIR3DL2, KIR3DL1, KIR2DL4, KIR3DS1 and KIR2DS1) Fc constructs to 95 different HLA class II molecules was investigated. Lymphocyte-activation gene 3 (LAG-3) protein, which has been previously described to be closely related to CD4 and to bind with high affinity to HLA class II molecules 12 , was used as a positive control. The LAG-3 Fc construct did indeed interact with all three HLA class II subtypes, HLA-DR, HLA-DQ and HLA-DP, while NKp30 and NKp46 Fc constructs did not bind to any of the tested HLA class II molecules. Furthermore, the different KIR Fc constructs tested did not exhibit significant binding to any of the HLA class II-coated beads above negative control levels ( Fig. 1a and Supplementary Fig. 1 ). In contrast, the NKp44 Fc construct displayed significant binding to a subset of HLA-DP molecules, including the HLA-DP401 molecule (molecule 8 in Fig. 1b) , which is highly prevalent in white populations 4 , but not to any of the HLA-DR or HLA-DQ molecules tested (Fig. 1a) . Using surface plasmon resonance (SPR), we confirmed binding of NKp44, but not NKp46, to HLA-DP401 with an affinity of 42.6 ± 16.2 µM (Fig. 1c,d ), which is within the range typically observed for immune receptor-ligand interactions [13] [14] [15] [16] . In contrast, NKp44 exhibited weak or no binding to HLA-DP301 and HLA-DQ2, respectively (Fig. 1c,d ). Taken together, these binding experiments identified an interaction between the NK cell receptor NKp44 and a subset of HLA-DP molecules, including direct and specific binding to the ectodomain of HLA-DP401 by SPR.
To further investigate functional consequences of the identified interactions between NKp44 and HLA-DP molecules, we generated a Jurkat reporter cell line stably expressing an NKp44ζ construct, composed of the extracellular domain of NKp44, the transmembrane domain of KIR3DL1 (to ensure DAP12-independent expression) and the cytoplasmic domain of the CD3ζ chain to mediate cellular activation upon receptor engagement and cross-linking. Upregulation of CD69 on the surface of NKp44ζ + Jurkat reporter cells was used as an activation readout for ligand engagement 11 .
In addition, NKp46ζ
+ and KIR2DL3ζ + Jurkat reporter cell lines were used as controls. To assess binding of NKp44 to HLA-DP molecules, biotinylated HLA-DP401 molecules (heterodimer of
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HLA-DPA1*01:03-HLA-DPB1*04:01) were initially used, and HLA-DR7 molecules (heterodimer of HLA-DRA1*01:01-HLA-DRB1*07:01) were used as controls. Both HLA class II molecules were loaded with the same human class II-associated invariant chain peptide (CLIP) (amino acids 87-101: PVSKMRMATPLLMQA).
NKp44ζ
+ Jurkat reporter cells displayed significant CD69 upregulation after co-incubation with HLA-DP401 CLIP molecules as compared to HLA-DR7 CLIP molecules (Fig. 2a,b) . The activation observed on exposure to HLA-DP401 CLIP molecules was specific to NKp44ζ
+ Jurkat reporter cells, and not observed with Jurkat cells transduced with other NK cell receptors (NKp46 or KIR2DL3) or untransduced Jurkat cells ( Fig. 2 and Supplementary Fig. 2 ). All Jurkat reporter cell lines showed robust activity to antibodies specific to the respective NK cell receptor that they were transduced with, demonstrating their functionality (Fig. 2a,b) . Furthermore, the proportion of NKp44ζ
+ Jurkat reporter cells expressing CD69 in response to HLA-DP401 CLIP was reduced when NKp44ζ
+ Jurkat reporter cells were pre-incubated with an anti-NKp44 blocking antibody (Fig. 2c) . As the HLA-DP allotypes exhibited differential levels of binding to NKp44 Fc constructs in the bead-based screening assay, we furthermore used two distinct HLA-DP molecules that strongly bound to NKp44 Fc constructs (HLA-DP401 and HLA-DP201 (HLA-DPA1*01:03-HLA-DPB1*02:01)), and two HLA-DP molecules that did not strongly bind to NKp44 Fc constructs (HLA-DP601 (HLA-DPA1*01:03-HLA-DPB1*06:01) and HLA-DP301 (HLA-DPA1*01:03-HLA-DPB1*03:01)). We observed HLA-DP molecule-specific activation of NKp44ζ + Jurkat cells by the two binders (HLA-DP401 more than HLA-DP201), but not by HLA-DP601 and HLA-DP301 (Fig. 2d) . Again, none of the HLA-DP allotypes induced activation of NKp46ζ + Jurkat reporter cells. These data show that NKp44 specifically interacts with certain HLA-DP allotypes, which can trigger functional cellular responses.
To further determine the functional response of NKp44-receptor binding to HLA-DP401 molecules in primary human innate immune cells, the response of NKp44
+ NK cells to plate-coated HLA class II molecules was assessed. NK cells freshly isolated from the peripheral blood of healthy donors did not express NKp44 on the cell surface, as has been previously reported 17 , and did not degranulate upon co-incubation with anti-NKp44, HLA-DR7 CLIP or HLA-DP401 CLIP ( Supplementary Fig. 3 ). We therefore induced NKp44 expression on the surface of isolated NK cells by incubating NK cells with IL-2 and IL-15 for 7 d ( Supplementary  Fig. 3a) . The functional response of cytokine-treated NK cells to plate-coated anti-NKp44, HLA-DR7 CLIP and HLA-DP401 CLIP was quantified by CD107a expression as a marker for degranulation 18 . Cytokine-treated NKp44 + NK cells showed an upregulation of CD107a upon co-incubation with HLA-DP401 CLIP molecules, which was notably higher than after co-incubation with HLA-DR7 CLIP molecules (Fig. 3a,b) . Furthermore, degranulation detected after incubation with HLA-DP401 CLIP was inhibited when cytokine-treated NK cells were pre-incubated with an antiNKp44 blocking antibody (Fig. 3b, right panel) , indicating that the observed functional response was mediated specifically by NKp44. Similar to the previous results using NKp44ζ + Jurkat reporter cells, degranulation of primary human NKp44 + NK cells co-incubated with distinct HLA-DP molecules was dependent on the HLA-DP allotype (Fig. 3c) . NKp44
+ cells displayed the highest degranulation after incubation with HLA-DP401 and HLA-DP201, while minimal degranulation was observed in response to HLA-DP601 and HLA-DP301 molecules. Furthermore, CD107a upregulation in primary NKp44
+ NK cells upon engagement with HLA-DP401 or HLA-DP201 was decreased by pre-incubation with an anti-NKp44 blocking antibody. By contrast, the blocking antibody had no effect on CD107a expression in primary NKp44
+ cells co-incubated with HLA-DP601 or HLA-DP301 molecules (Fig. 3c) . NK cells from each tested donor degranulated robustly after co-incubation with the NK cell-sensitive tumor cell line K562, and responses to K562 cells were not influenced by pre-incubation of NK cells with an antiNKp44 blocking antibody (data not shown). In summary, these data indicate a functional modulation of NK cell activity by a subset of HLA-DP molecules mediated by the NK cell receptor NKp44.
HLA-DP molecules can present a large array of different peptides on the cell surface after replacing the CLIP peptide 19 , and recognition of these peptides has been investigated in the context of T cell receptors expressed on CD4
+ T cells [20] [21] [22] . Given the identification of binding of NKp44 to HLA-DP, we tested whether differences in peptides presented by HLA-DP401 have an impact on recognition by NKp44.
Using the NKp44ζ
+ Jurkat reporter cell assay described above, we compared CD69 expression in response to HLA-DP401 molecules refolded either with CLIP or with a number of pathogen-or selfderived peptides (peptide sequences are shown in Supplementary  Table 1 ). HLA-DR7 molecules refolded with either CLIP or a human immunodeficiency virus 1 (HIV-1)-derived Gag peptide were used as controls. We observed a clear impact of the different peptides bound to HLA-DP401 on activation of NKp44ζ + Jurkat reporter cells (Fig. 4a) , with the HLA-DP401 CLIP complex mediating the strongest activation and the HLA-DP401-Clostridium tetani tetanus toxin (C. tetani TT) peptide complex inducing a significantly lower response. In contrast, HLA-DR7 monomers did not trigger any activation of NKp44ζ + Jurkat reporter cells, either in complex with CLIP or in complex with the HIV-1 Gag peptide (Fig. 4a) . Similar to the observations using NKp44ζ
+ Jurkat reporter cells, the activation of primary NKp44
+ NK cells incubated with HLA-DP401 was also modulated by the specific HLA-DP-bound peptide. While plate-coated HLA-DP401 CTAG1 and HLA-DP401 HIV-1 Env complexes were able to trigger degranulation of cytokine-treated primary NK cells, HLA-DP401 molecules loaded with C. tetani TTor human oxytocinase-derived peptides were not (Fig. 4b) . . Each dot indicates an individual HLA class II allele. Binding of LAG-3, NKp30, NKp46 and KIR Fc constructs to HLA class II-coated beads was determined in one single experiment (n = 1). Binding of NKp44 Fc construct to HLA class II beads was determined in three independent biological replicates and MFI values of all experiments (n = 3) are depicted as mean values for each allele. The 95 HLA class II alleles were grouped according to HLA-DR, HLA-DQ and HLA-DP. The horizontal line shows the median of each HLA class II group. Error bars depict the interquartile range of each group. Statistical comparisons between HLA molecule types were done using data from each replicate in a mixed effects linear regression model. ****P < 0.0001. b, NKp44 Fc construct binding to different HLA-DP-coated beads was determined in three independent biological replicates and data of all independent experiments (n = 3) are depicted as MFI. Floating bars indicate the median, minimum and maximum MFI of each HLA-DP allele tested. HLA-DP molecules that exhibited higher binding to the NKp44 Fc construct than to the positive control in at least one assay are marked in red. 
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In conclusion, engagement of NKp44 by HLA-DP401 induced degranulation of NK cells, and this response was further modulated in a peptide-dependent manner. These results suggest that changes in peptide repertoires that occur during infections or inflammatory processes might impact not only recognition of HLA-DP-expressing cells by CD4 + T cells 23, 24 , but also recognition by NKp44 . To further investigate the physiological interaction of membrane-bound NKp44 with membrane-bound HLA-DP molecules, we generated four HLA-DP-expressing Jurkat (clone E6.1) cell lines, JE6.1-DP401, JE6.1-DP201, JE6.1-DP601 and JE6.1-DP301 (Supplementary Fig. 4a ). Jurkat cells are class II major histocompatibility complex transactivator (CIITA)-deficient and therefore lack the expression of all HLA class II molecules 31 , enabling the controlled and specific investigation of interactions between NKp44 and membrane-bound HLA-DP. In line with our binding data, HLA-DP401-expressing JE6.1 cells induced significantly higher NKp44ζ
+ reporter cell activation than HLA-DP601-and HLA-DP301-expressing JE6.1 cells (Fig. 5a) . NKp44ζ
+ reporter cell activity in response to JE6.1-DP201 cells was less pronounced, yet the percentage of CD69 + reporter cells was higher upon coincubation with JE6.1-DP201 cells compared to JE6.1-DP601 and JE6.1-DP301 cells. In contrast, NKp46ζ
+ Jurkat reporter cells did not display significant upregulation of CD69 after co-incubation with any of the JE6.1-DP cell lines. Since we had observed a peptide-dependent activation of NKp44ζ
+ Jurkat reporter cells upon HLA-DP engagement, with HLA-DP401 CLIP molecules inducing the highest activation (Fig. 4a) , we subsequently examined the effect of CLIP surface presentation on NKp44ζ
+ Jurkat reporter cell activity. Jurkat cells are negative for the HLA class II-associated invariant chain 32 and consequently do not display CLIP on their surface, even after transduction with HLA-DP molecules, allowing for external pulsing with CLIP. Addition of CLIP to JE6.1 cells transfected with HLA-DP401, HLA-DP201, HLA-DP301 and HLA-DP601 resulted in enhanced HLA-DP-expression levels ( Supplementary  Fig. 4b ), indicating stabilization of HLA-DP expression by exogenous CLIP. While CLIP-pulsed JE6.1-DP201 cells induced slightly elevated activation of NKp44ζ + Jurkat reporter cells compared with unpulsed JE6.1-DP201 cells, CLIP pulsing did not increase CD69 expression of NKp44ζ + Jurkat reporter cells after co-incubation with JE6.1-DP401, JE6.1-DP601 and JE6.1-DP301, compared with the respective unpulsed JE6.1-DP cells. Most importantly, the overall hierarchy of NKp44 + cell activation remained consistent with CLIP-pulsed JE6.1-DP401 and JE6.1-DP201 cells triggering significantly higher CD69 expression on NKp44ζ + Jurkat reporter cells than CLIP-pulsed JE6.1-DP601 and JE6.1-DP301 cells (Fig. 5b ). These data demonstrate that functional responses resulting from membrane-bound NKp44-HLA-DP interactions were more strongly influenced by the respective HLA-DP allotype than by the presentation of CLIP on HLA-DP molecules.
NKp44 (NCR2) is one of the three NCRs expressed by NK cells 17 .
NKp44
+ innate immune cells have been implicated in autoimmune diseases, such as inflammatory bowel disease 33, 34 , and several studies have investigated the functional characteristics of NKp44 + NK cells 17, 35, 36 . NKp44 was initially described to be an activating NK cell receptor, although it was subsequently demonstrated that some splice isoforms of NKp44 can also negatively regulate NK cell function 37 . Although the function of NKp44 + NK cells has been extensively studied, a widely expressed cellular ligand for NKp44 has remained elusive and controversial. Several cellular and viral NKp44 ligands have been proposed, such as viral hemagglutinin 38, 39 , proliferating cell nuclear antigen 40 and mixed-lineage leukemia protein 5 (ref. 41 ), but other studies have failed to reproduce these findings 42 . Platelet-derived growth factor (PDGF)-DD has been described as a soluble ligand binding for NKp44 (ref. 42 ). PDGF-DD engagement of NKp44 triggered cytokine secretion by NK cells, and this induced tumor cell-growth arrest 42 . Here we identified a subset of HLA-DP molecules as cellular ligands for NKp44 and demonstrated that binding of these HLA-DP molecules triggered the activation of NKp44
+ reporter cells and primary NK cells expressing NKp44. Neither NKp44 nor HLA-DP exist in mice 43, 44 and the absence of small-animal models to study NKp44
+ NK cells has certainly complicated the identification of its ligand. It has been suggested that expression of NKp44 evolved over the last 23-25 million years, and inefficient transcription of NKp44 in macaques has been described, whereas NKp44 surface expression has been detected on chimpanzee-derived NK cells 43 . The absence of an NKp44 gene within the murine triggering receptor expressed on myeloid cells (TREM) gene cluster, within which the NKp44 gene is encoded in humans 45 , and the insufficient transcription within macaques indicate a functional role of NKp44 at later stages in evolution in Homo sapiens sapiens and closely related species. Similarly, the diversification of HLA-DP between different species 46 and the interchangeable function of the distinct HLA class II molecules within one species, as described for rodents 47 , suggests a functional impact of HLA-DP-NKp44 interactions primarily in humans.
HLA-DP is constitutively expressed on antigen-presenting cells and B cells, and HLA-DP molecules have been shown to be upregulated on non-hematopoietic tissues in response to inflammation 24 . Specific HLA-DP allotypes, as well as the expression levels of HLA-DP molecules, have been associated with a variety of human diseases, including graft-versus-host disease following hematopoietic cell transplantation 8 , hepatitis B virus (HBV) infection [5] [6] [7] and autoimmune diseases 9, 10 . In the setting of graft-versus-host + cells following incubation on non-coated wells (blank) was subtracted from all samples. Corrected values are illustrated as median with interquartile range as determined in eight independent experiments (n = 8). Two-tailed Wilcoxon matched pairs signed-rank test was used to calculate the difference of CD69 + cells after co-incubation with HLA-DR7 CLIP and HLA-DP401 CLIP molecules. **P = 0.008. c, Reporter cell activity of NKp44ζ
+ Jurkat reporter cells in response to anti-NKp44, HLA-DR7 CLIP and HLA-DP401 CLIP was determined in the presence of a purified mouse IgG1 isotype or a purified anti-NKp44 (both at a final concentration of 10 µg ml disease and HBV infection, it has been suggested that disease outcome is linked to specific single nucleotide polymorphisms (SNPs) in the 3′ untranslated region (UTR) region of the gene encoding the HLA-DP β-chain, which mark differential HLA-DP expression levels on the cell surface 7, 8 . Low expression of HLA-DP was associated with HBV clearance, whereas high expression of HLA-DP was associated with persistence of HBV and a higher risk of developing graft-versus-host disease. Interestingly, HLA-DP401 and B l a n k B l a n k B l a n k HLA-DP201, the two HLA-DP molecules that induced strong NKp44 binding and activation of NKp44ζ + reporter cells, are both in linkage disequilibrium with the SNP associated with low HLA-DP expression (496A, rs9277534) and recovery from HBV infection. In contrast, the two HLA-DP molecules tested that exhibited no or only limited binding to NKp44 Fc constructs and low activation of NKp44ζ + reporter cells, HLA-DP601 and HLA-DP301, are associated with high HLA-DP surface expression (496G) and HBV persistence 7 . These data indicate that the levels of HLA-DP expression and NKp44 binding might have co-evolved, with high-expressed HLA-DP molecules mediating no or little binding to NKp44, possibly to avoid induction of autoimmunity. However, in response to inflammation, such as during HBV infection, HLA-DP molecules have been shown to be upregulated 24 , and upregulation of normally low-expressed HLA-DP molecules that serve as ligands for NKp44 might enable recognition of infected cells by NKp44
+ NK cells and viral clearance. The interaction identified here between a subset of HLA-DP molecules and NKp44 will now allow for functional assessment of the consequences of these interactions for the outcome of diseases that have been associated with HLA-DP genotypes and expression levels.
The precise regions within NKp44 and HLA-DP that are responsible for the binding of these molecules remain unknown. While NKp44 consistently bound to a subset of HLA-DP molecules, binding to these HLA-DP molecules was not solely dependent on either the α-or β-chain of the respective HLA-DP molecule alone, indicating a binding region determined by both chains. Identification of the specific binding sites within the HLA-DP molecules for NKp44, and how binding is further modulated by the HLA-DPpresented peptide, will be a critical step towards understanding the structural requirements for these interactions. It is well established that specific peptides presented by HLA class I molecules impact binding of KIRs [25] [26] [27] [28] [29] [30] , and we also observed an impact of the HLA-DP-presented peptides on the activity of NKp44-expressing cells (Fig. 4) . It is therefore possible that NKp44 might bind to additional HLA class II molecules other than the ones identified in this study in situations in which these molecules present specific peptides. However, using membrane-bound HLA-DP molecules presenting a broad array of different peptides, we observed consistent hierarchies of interactions with NKp44, with HLA-DP401 always exhibiting the strongest binding. These data suggest that HLA class II allotypes represent the principal determinants for NKp44 binding, reminiscent of KIR binding to HLA class I, which is strongly defined by the respective HLA class I allotypes 48 . In conclusion, this study identified an interaction between a subset of HLA-DP molecules and the NK cell receptor NKp44 that has a functional impact on NKp44
+ NK cell activity, implicating HLA class II molecules in the regulation of innate immunity.
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